title: Management of neuroendocrine tumors of unknown origin.
abstract: Neuroendocrine tumors (NETs) of unknown origin account for more than 10% of all NETs. Most of these tumors are poorly differentiated and, thus, very aggressive. Establishing the location of the primary tumor can be challenging. Workup of these NETs of unknown origin includes a thorough family history, immunohistochemistry, imaging, and OctreoScan. If the location of the primary malignancy is not determined, treatment is often initiated based on the grade and level of differentiation of the tumor, with well- and moderately differentiated tumors treated as carcinoid tumors, whereas poorly differentiated tumors are treated similarly to small cell tumors. Therapy is chosen based on symptoms and with the goal of debulking tumor when feasible and safe.
authors.affiliation: Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, 676 North St. Clair Street, Chicago, IL 60611, USA.
authors.forename: Ariel
authors.initials: A
authors.lastname: Polish
authors.forename: Maxwell T
authors.initials: MT
authors.lastname: Vergo
authors.forename: Mark
authors.initials: M
authors.lastname: Agulnik
mesh_terms: D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D004502:Education, Medical, Continuing; D006801:Humans; D008495:Medical Oncology / Q000193:education; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis / Q000628:therapy*; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy*